扩散加权成像产生的明显扩散系数地图上的幽灵标志:额外的MRI诊断标志物用于极端骨髓炎
Angela He1, Mina Guirguis1, Flavio Duarte Silva1
1Department of Radiology, UT Southwestern Medical Center, Dallas, Texas, United States.
The Indian journal of radiology & imaging
|December 19, 2024
概括
表面扩散系数 (ADC) 地图上的幽灵标志是骨髓炎 (OM) 的更敏感指标,而不是T1加权的成像标志. 这种高度特定的标志有助于诊断OM,显示出与其他方法相似的良好准确性.
科学领域:
- 放射学 放射学是一门学科.
- 医疗成像医学成像
- 整形外科 整形外科 整形外科
背景情况:
- 骨髓炎 (OM) 的诊断依赖于成像.
- 使用T1加权 (T1W) 图像标志,如"幽灵标志"和"半影标志".
- 这些标志的诊断性能,特别是在ADC地图上,需要进一步评估.
研究的目的:
- 评估T1W成像中的"幽灵标志"和"半阴影标志"的灵敏度,特异性和读者间可靠性.
- 在表面扩散系数 (ADC) 地图上评估"幽灵标志",用于诊断 extremity OM.
- 为了比较这些成像标志的诊断准确性.
主要方法:
- 178个MRI扫描 (41个OM,137个非OM) 的回顾性横截面研究.
- 两个肌肉骨放射科医生独立评估T1W和ADC地图标志,对诊断失明.
- 诊断性表现指标 (灵敏度,特异性,准确性) 和科恩的卡帕 (Cohen's kappa) 计算了读者之间的一致性.
主要成果:
- 读者之间的一致性对于成像征兆是公平的,对于OM诊断是中度的 (0.60).
- 对OM的敏感性很低:半阴影标志 (T1W) 3.7%,幽灵标志 (T1W) 9.8%,幽灵标志 (ADC) 19.5%.
- 具体性很高:半阴影符号 (T1W) 98.9%,幽灵符号 (T1W) 97.8%,幽灵符号 (ADC) 94.5%. 所有标志都显示出很好的准确性 (76-78%).
结论:
- 在ADC地图上的幽灵标志是OM的高度特定且比T1W标志更敏感的标志.
- 虽然所有评估的符号都具有很好的准确性,但ADC上的幽灵符号提供了更好的灵敏度.
- 在ADC上的幽灵标志可以作为一种有价值的额外工具来检测骨髓炎.
相关概念视频
Assessment of Diffusion and Perfusion
2.0K
Understanding and evaluating diffusion and perfusion is critical in assessing a patient's respiratory and circulatory health. These processes play key roles in maintaining the body's internal environment, ensuring that tissues receive adequate oxygen while waste products are efficiently removed.
The Role of Diffusion in Respiration
Diffusion is the process by which molecules move from an area of higher concentration to an area of lower concentration. In the respiratory system, this...
The Role of Diffusion in Respiration
Diffusion is the process by which molecules move from an area of higher concentration to an area of lower concentration. In the respiratory system, this...
2.0K
Magnetic Resonance Imaging
7.6K
Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...
7.6K


